Prot# PLX108-05: A Phase 1/2 Safety and Efficacy Study of Orally Administered PLX3397 in Adults With Relapsed or Refractory Flt--ITD positive Acute Myeloid Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date9/1/119/1/15

Funding

  • Plexxikon Inc. (PLX108-05)